Huntington’s disease was long thought to be caused by the slow buildup of a toxic protein, but new research has reveale | This week on "The Top Line," we hear from Steven McCarroll, Ph.D., whose ...

Huntington’s disease is an inherited neurological disorder causing movement, cognitive, and behavioral issues. Effective management includes medical treatments, therapies, nutritional support ...

Huntington’s disease is a brain disorder that can affect various functions, including the ability to swallow — particularly as the disease progresses. Huntington’s disease is a ...

While Huntington’s disease is progressive and worsens over time, understanding what is to come can help someone with this condition plan for the road ahead. Huntington’s disease is a ...

LETI-101 has demonstrated therapeutically relevant reductions of mutant huntingtin (HTT) protein, exceeding 80%, while preserving essential ...

A drug originally developed for high blood pressure could find a new use in the treatment of Huntington's disease, thanks to an artificial intelligence-based drug discovery programme at Spain's ...

MMJ-002 has received Orphan Drug designation for Huntington's disease, which provides market exclusivity for seven years and various tax incentives. Additionally, the FDA has endorsed key aspects ...

U.S.A.I.D. Advertisement Supported by Organizations funded by the United States helped keep dangerous pathogens in check around the world. Now many safeguards are gone, and Americans may pay the ...

Prilenia Therapeutics is planning to file its Huntington’s disease therapy pridopidine in the EU, despite mixed results in a phase 3 trial. Pridopidine is an oral agonist of the S1R protein ...

HUNTINGTON, W.Va. (WCHS) — Huntington's new administration wants to make sure people are not only safe, but they also feel safe when they come to the city. That's why there is an ongoing effort ...